Mayo Clinic: Central Nervous System Neoplasms trials

The registry lists 12 Central Nervous System Neoplasms studies with Mayo Clinic as lead sponsor. 2 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience ResearchRecruitingNCT06117930
• Cerebrospinal Fluid Biomarkers for Brain TumorsRecruitingNCT04692324
• Patient and Caregiver Priorities in Neuro-oncology CareCompletedNCT06676306
• A Study of Metabolic Agents Following Brain RadiationCompletedNCT06150547
• Pharmacodynamic Analyses of Metabolic Agents Following Brain RadiationWithdrawnNCT05720624Phase 1
• Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyCompletedNCT04456140Phase 1
• Brain Imaging Changes Following Proton Therapy for Pediatric Primary Central Nervous System and Base of Skull TumorsCompletedNCT04296617
• Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System TumorsCompletedNCT04217694Early Phase 1
• Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing SurgeryCompletedNCT03071913
• Cognitive Function After Treatment of Primary CNS MalignancyCompletedNCT03055364
• Etoposide Plus Cisplatin in Treating Patients With Recurrent EpendymomasCompletedNCT00002876Phase 2
• Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS TumorsCompletedNCT00002472Phase 2